Bispecific GD2 x B7-H3 Antibody Improves Tumor Targeting and Reduces Toxicity while Maintaining Efficacy for Neuroblastoma
A. K. Erbe, A. S. Feils, A. Hampton, Z. T. Rosenkrans, M. Felder, J. Wiwczar, D. J. Gerhardt, M. Bercher, B. Wenke, C. Haertle, M. Heck, S. N. VandenHeuvel, E. Frankel, M. Nielsen, D. Spiegelman, , P. M. Sondel
bioRxiv · May 23, 2024 · PreprintCancer Biology